1 of 1
Story summary
- cbdMD, Inc. (YCBD) entered into an Employment Agreement with CEO T. Ronan Kennedy on November 28, 2025, including a base salary and a stock award.
- The board approved a 2025 Equity Compensation Plan to replace the expired 2015 plan, subject to shareholder approval at the 2026 meeting.
- Analysts rate cbdMD stock (YCBD) as Sell with a $1.00 price target, citing financial challenges, negative earnings, and cash flow issues.
